Search research articles
Contact Us
Filters
Showing results (461-470 of 478) with videos related to
Page
of 48
Sort By:
Bulletin Du Cancer
|
March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]
T Le Chevalier, M Gottfried, U Gatzemeier, et al.
Leukemia & Lymphoma
|
May 7, 1998
Primary mediastinal B-cell lymphoma: update of its clinicopathologic features
M Paulli, M Lazzarino, U Gianelli, et al.
Anticancer Research
|
May 6, 1998
Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer
M T Nobile, M C Barzacch, O Sanguineti, et al.
Oncology (Williston Park, N.Y.)
|
August 1, 1997
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer
J M Nabholtz, B Thuerlimann, W R Bezwoda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2002
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
J Cassidy, C Twelves, E Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest
P F Conte, M Bruzzone, F Carnino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1996
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer
M Venturini, A Michelotti, L Del Mastro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2003
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group
M S Aapro, F H van Wijk, M E L van der Burg, et al.
Gynecologic Oncology
|
June 1, 1997
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest
M Bruzzone, A Rubagotti, A Gadducci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)
F Di Costanzo, A Sobrero, S Gasperoni, et al.
Page
of 48
Search research articles
Search
Showing results (461-470 of 478) with videos related to
Sort By:
Page
of 48
Bulletin Du Cancer
|
March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]
T Le Chevalier, M Gottfried, U Gatzemeier, et al.
Leukemia & Lymphoma
|
May 7, 1998
Primary mediastinal B-cell lymphoma: update of its clinicopathologic features
M Paulli, M Lazzarino, U Gianelli, et al.
Anticancer Research
|
May 6, 1998
Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer
M T Nobile, M C Barzacch, O Sanguineti, et al.
Oncology (Williston Park, N.Y.)
|
August 1, 1997
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer
J M Nabholtz, B Thuerlimann, W R Bezwoda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2002
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
J Cassidy, C Twelves, E Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest
P F Conte, M Bruzzone, F Carnino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1996
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer
M Venturini, A Michelotti, L Del Mastro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 9, 2003
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group
M S Aapro, F H van Wijk, M E L van der Burg, et al.
Gynecologic Oncology
|
June 1, 1997
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest
M Bruzzone, A Rubagotti, A Gadducci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)
F Di Costanzo, A Sobrero, S Gasperoni, et al.
Page
of 48